Ken Griffin Acrivon Therapeutics, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Acrivon Therapeutics, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 2,119,646 shares of ACRV stock, worth $0. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,119,646
Previous 1,680,027
26.17%
Holding current value
$0
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ACRV
# of Institutions
56Shares Held
23.6MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA8.34MShares$00.0% of portfolio
-
Perceptive Advisors LLC New York, NY5.36MShares$00.0% of portfolio
-
Sands Capital Ventures, LLC Arlington, VA2.12MShares$00.0% of portfolio
-
Marshall Wace, LLP London, X0949KShares$00.0% of portfolio
-
Wellington Management Group LLP Boston, MA888KShares$00.0% of portfolio